Elite members get real-time data, technical charting, alerts, and no ads - starting at $24.96/mo.
Try Elite for Free
Index
RUT
Market Cap
713.98M
Enterprise Value
844.63M
Income
4.80M
Sales
249.72M
Book/sh
33.73
Cash/sh
5.49
Employees
717
IPO
Feb 29, 1984
P/E
150.96
Forward P/E
11.72
PEG
-
P/S
2.86
P/B
3.78
P/C
23.26
P/FCF
13.50
EV/EBITDA
18.59
EV/Sales
3.38
Quick Ratio
1.32
Current Ratio
1.79
Debt/Eq
0.85
LT Debt/Eq
0.81
Option/Short
No / Yes
EPS (ttm)
0.85
EPS next Y
10.88
EPS next Q
2.29
EPS this Y
-10.69%
EPS next Y
6.82%
EPS next 5Y
-
EPS past 3/5Y
90.85% 13.55%
Sales past 3/5Y
4.38% 13.22%
EPS Y/Y TTM
842.96%
Sales Y/Y TTM
3.04%
EPS Q/Q
-42.44%
Sales Q/Q
1.00%
Insider Own
4.24%
Insider Trans
-3.02%
Inst Own
94.24%
Inst Trans
6.38%
ROA
1.12%
ROE
2.66%
ROIC
1.40%
Gross Margin
57.35%
Oper. Margin
9.00%
Profit Margin
1.92%
SMA20
-1.75%
SMA50
1.23%
SMA200
24.35%
Trades
Shs Outstand
5.60M
Shs Float
5.36M
52W High
144.35 -11.61%
52W Low
69.51 83.56%
Volatility
3.64% 3.81%
ATR (14)
4.83
RSI (14)
50.38
Beta
1.08
Rel Volume
0.98
Avg Volume
133.24K
Volume
43,090
Perf Week
1.13%
Perf Month
-5.23%
Perf Quarter
26.39%
Perf Half Y
25.98%
Perf YTD
62.54%
Perf Year
61.67%
Perf 3Y
32.14%
Perf 5Y
-57.89%
Perf 10Y
5.01%
Prev Close
125.16
Price
127.59
Change %
1.94%
Date Action Analyst Rating Change Price Target Change
Aug-07-25Upgrade Wells Fargo Underweight → Equal Weight $67
Aug-28-24Initiated Wells Fargo Underweight $120
Jan-04-24Upgrade Evercore ISI In-line → Outperform $100 → $125
Jan-04-21Downgrade Evercore ISI Outperform → In-line $300
Nov-10-20Initiated KeyBanc Capital Markets Sector Weight $287
Oct-02-20Initiated JP Morgan Neutral $260
Dec-04-19Initiated Jefferies Buy
Aug-26-19Initiated Evercore ISI Outperform $250
Jun-10-16Downgrade Sidoti Buy → Neutral
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Owens Gary MFormer OfficerAug 27 '26Proposed Sale127.7520,3582,600,734Aug 27 03:33 PM
Owens Gary MFormer OfficerAug 21 '26Proposed Sale122.5020,0002,450,059Aug 21 03:53 PM
Capone Mark ChristopherDirectorAug 15 '26Option Exercise0.002,78406,213Aug 17 07:40 PM
Alltoft Jennifer SadieDirectorAug 15 '26Option Exercise0.002,78407,662Aug 17 07:32 PM
Ladiwala Shiraz ShabanaliDirectorAug 15 '26Option Exercise0.003,810012,333Aug 17 05:55 PM
Hall ShannonDirectorAug 15 '26Option Exercise0.002,78406,973Aug 17 05:46 PM
Tripeny R TonyDirectorAug 15 '26Option Exercise0.002,78409,082Aug 17 05:30 PM
Sullivan John JamesDirectorAug 15 '26Option Exercise0.002,784020,618Aug 17 05:01 PM
Sullivan John JamesDirectorAug 13 '26Sale112.807,093800,09017,834Aug 17 12:18 PM
Kadia SiddharthaPresident and CEOAug 13 '26Buy112.807,093800,0907,093Aug 17 11:49 AM
Tripeny R TonyDirectorAug 13 '26Buy113.69900102,3216,298Aug 17 11:27 AM
Crennen Lyndsey ElizabethCAOJun 18 '26Option Exercise95.1072669,0432,199Jun 23 01:34 PM
Crennen Lyndsey ElizabethCAOJun 22 '26Sale89.5044239,5602,020Jun 23 01:34 PM
Archbold Brian DavidSVP OperationsJun 18 '26Option Exercise95.103,324316,1127,034Jun 23 01:02 PM
Archbold Brian DavidSVP OperationsJun 22 '26Sale89.502,516225,1876,377Jun 23 01:02 PM
Sakys JohnCFOJun 18 '26Option Exercise95.103,792360,61920,330Jun 23 12:23 PM
Sakys JohnCFOJun 22 '26Sale89.502,827253,02219,785Jun 23 12:23 PM
Sakys JohnOfficerJun 22 '26Proposed Sale89.502,827253,022Jun 22 03:56 PM
Archbold Brian DavidOfficerJun 22 '26Proposed Sale89.502,516225,187Jun 22 03:51 PM
Archbold Brian DavidSVP OperationsJun 16 '26Sale101.271,151116,5583,710Jun 17 12:23 PM
Crennen Lyndsey ElizabethCAOJun 16 '26Sale101.2711811,9501,473Jun 17 12:19 PM
Sakys JohnCFOJun 16 '26Sale101.271,223123,85016,538Jun 17 12:09 PM
Archbold Brian DavidOfficerJun 16 '26Proposed Sale101.271,151116,558Jun 16 03:33 PM
Sakys JohnOfficerJun 16 '26Proposed Sale101.271,223123,850Jun 16 03:31 PM
Owens Gary MFormer OfficerJun 16 '26Proposed Sale101.273,706375,296Jun 16 03:29 PM
Archbold Brian DavidSVP OperationsJun 15 '26Option Exercise104.082,454255,4124,861Jun 16 02:44 PM
Sakys JohnCFOJun 15 '26Option Exercise104.082,717282,78517,761Jun 16 02:15 PM
Ladiwala Shiraz ShabanaliDirectorMar 10 '26Buy72.233,500252,8058,523Mar 10 05:43 PM
Capone Mark ChristopherDirectorMar 10 '26Buy76.351,30199,3313,429Mar 10 03:46 PM
Tripeny R TonyDirectorMar 10 '26Buy76.001,31599,9405,398Mar 10 03:39 PM
Owens Gary MPresident and CEOOct 27 '25Option Exercise0.0011,558064,135Oct 28 03:08 PM
Mesa Laboratories, Inc. engages in the design, manufacture, and market of instruments and disposable products utilized in healthcare, pharmaceutical, food and beverage, medical device, and petrochemical industries. It operates through the following segments: Sterilization and Disinfection Control, Clinical Genomics, Biopharmaceutical Development, and Calibration Solutions. The Sterilization and Disinfection Control segment manufactures and sells biological, cleaning, and chemical indicators. The Clinical Genomics segment division develops, manufactures and sells highly sensitive, low-cost, high-throughput genetic analysis tools and related consumables and services that enable clinical research labs and contract research organizations. The Biopharmaceutical Development segment caters and sells automated systems for protein analysis and peptide synthesis solutions. The Calibration Solutions segment focuses on the quality control products using principles of advanced metrology to enable customers to measure and calibrate critical parameters in applications such as renal care, environmental and process monitoring, gas flow, air quality and torque testing, primarily in medical device manufacturing, pharmaceutical manufacturing, laboratory and hospital environments. The company was founded by Luke R. Schmieder on March 26, 1982 and is headquartered in Lakewood, CO.
VP & CFOMr. John V. Sakys CPA
Senior Vice President of Operations & Continuous ImprovementMr. Brian David Archbold
M.S.Dr. Siddhartha Chandrakant Kadia B.E.
Chief Accounting OfficerMs. Lyndsey Crennen